WestEnd Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.4M | Sell |
443,199
-23,176
| -5% | -$2.22M | 0.93% | 33 |
|
|
2025
Q4 | $44.8M | Buy |
466,375
+1,641
| +0.4% | +$159K | 1.04% | 28 |
|
|
2025
Q3 | $44.3M | Sell |
464,734
-8,573
| -2% | -$788K | 1.04% | 25 |
|
|
2025
Q2 | $41.3M | Buy |
473,307
+9,796
| +2% | +$831K | 1.02% | 29 |
|
|
2025
Q1 | $41.7M | Sell |
463,511
-7,284
| -2% | -$652K | 1.11% | 24 |
|
|
2024
Q4 | $37.6M | Sell |
470,795
-20,364
| -4% | -$1.76M | 0.96% | 29 |
|
|
2024
Q3 | $44.2M | Buy |
491,159
+7,116
| +1% | +$599K | 1.09% | 24 |
|
|
2024
Q2 | $38.1M | Buy |
484,043
+86,268
| +22% | +$7.07M | 0.98% | 31 |
|
|
2024
Q1 | $34.7M | Buy |
397,775
+6,210
| +2% | +$530K | 0.9% | 29 |
|
|
2023
Q4 | $32.3M | Sell |
391,565
-10,741
| -3% | -$819K | 0.88% | 31 |
|
|
2023
Q3 | $31.5M | Sell |
402,306
-14,024
| -3% | -$1.17M | 0.95% | 31 |
|
|
2023
Q2 | $36.7M | Buy |
+416,330
| New | +$35.8M | 1.08% | 22 |
|
|
2023
Q1 | – | Sell |
-346,004
| Closed | -$28.2M | – | 24 |
|
|
2022
Q4 | $26.9M | Sell |
346,004
-50,660
| -13% | -$4.11M | 0.88% | 30 |
|
|
2022
Q3 | $32M | Sell |
396,664
-5,546
| -1% | -$498K | 1.07% | 25 |
|
|
2022
Q2 | $36.1M | Buy |
+402,210
| New | +$40.8M | 1.14% | 23 |
|
|
2022
Q1 | – | Sell |
-357,482
| Closed | -$37.8M | – | 19 |
|
|
2021
Q4 | $37M | Buy |
+357,482
| New | +$41.4M | 1.01% | 32 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 22 |
|
|
2021
Q2 | – | Sell |
-342,066
| Closed | -$42.9M | – | 28 |
|
|
2021
Q1 | $40.4M | Buy |
342,066
+8,192
| +2% | +$960K | 1.62% | 27 |
|
|
2020
Q4 | $39.1M | Sell |
333,874
-11,919
| -3% | -$1.31M | 1.98% | 20 |
|
|
2020
Q3 | $35.9M | Buy |
345,793
+6,772
| +2% | +$680K | 2.12% | 22 |
|
|
2020
Q2 | $31.1M | Buy |
339,021
+33,137
| +11% | +$3.18M | 2.09% | 27 |
|
|
2020
Q1 | $27.6M | Sell |
305,884
-3,128
| -1% | -$333K | 2.31% | 22 |
|
|
2019
Q4 | $35.1M | Sell |
309,012
-18,391
| -6% | -$2.02M | 2.64% | 11 |
|
|
2019
Q3 | $35.6M | Sell |
327,403
-20,545
| -6% | -$2.14M | 2.92% | 9 |
|
|
2019
Q2 | $33.9M | Sell |
347,948
-42,651
| -11% | -$3.89M | 2.95% | 14 |
|
|
2019
Q1 | $35.6M | Buy |
390,599
+10,456
| +3% | +$936K | 3.34% | 16 |
|
|
2018
Q4 | $34.6M | Sell |
380,143
-49,528
| -12% | -$4.63M | 3.71% | 5 |
|
|
2018
Q3 | $42.3M | Sell |
429,671
-10,288
| -2% | -$951K | 4.04% | 5 |
|
|
2018
Q2 | $37.7M | Sell |
439,959
-101,255
| -19% | -$8.46M | 3.91% | 12 |
|
|
2018
Q1 | $43.4M | Sell |
541,214
-4,832
| -0.9% | -$399K | 4.09% | 12 |
|
|
2017
Q4 | $44.1M | Sell |
546,046
-24,579
| -4% | -$1.97M | 4.08% | 14 |
|
|
2017
Q3 | $44.4M | Sell |
570,625
-63,710
| -10% | -$5.29M | 3.89% | 18 |
|
|
2017
Q2 | $56.3M | Sell |
634,335
-53,657
| -8% | -$4.52M | 4.82% | 3 |
|
|
2017
Q1 | $55.4M | Buy |
687,992
+47,533
| +7% | +$3.71M | 4.63% | 14 |
|
|
2016
Q4 | $45.6M | Sell |
640,459
-145,953
| -19% | -$11.5M | 3.64% | 20 |
|
|
2016
Q3 | $67.9M | Buy |
+786,412
| New | +$68.5M | 4.87% | 13 |
|
Other funds holding MDT
VCM
VPM
WestEnd Advisors's MDT Position: Q1 2026 in Review
WestEnd Advisors reduced its Medtronic (MDT) stake by 5% in Q1 2026, selling an estimated $2.22M and leaving 443,199 shares worth $38.4M. The position accounts for 0.93% of the portfolio, ranked #33.
WestEnd Advisors first reported a position in MDT in Q3 2016 and has held it in 35 quarters since. The position peaked at $67.9M in Q3 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- WestEnd Advisors held 443,199 shares of Medtronic worth $38.4M as of Q1 2026.
- WestEnd Advisors sold 23,176 Medtronic shares in Q1 2026, an estimated $2.22M.
- Medtronic made up 0.93% of WestEnd Advisors's portfolio in Q1 2026, its #33 holding.
- WestEnd Advisors first reported a position in Medtronic in Q3 2016 and has held it in 35 quarters since.
- WestEnd Advisors's Medtronic position peaked at $67.9M in Q3 2016.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.